Organic Letters
Letter
in the absence of photosensitizer (entry 18) or without
photoexcitation (entry 19), and this suggested that both are
necessary to promote the reaction.15
From this first successful set of experiments, a plausible
mechanism can already be proposed starting from the imine,
generated prior to irradiation by condensation between
diamine 1 and aldehyde 2a (Scheme 2). In the first step, the
92% yield. As exceptions, 4-cyanobenzaldehyde led to a lower,
albeit satisfactory, yield of 70%, whereas 4-nitrobenzaldehyde
failed to give the desired product. The heteroaromatics
thiofurfural, furfural, and nicotinaldehyde were good perform-
ers in this CLAP transformation, furnishing 3k, 3l, and 3m in
77, 87, and 80% yields, respectively. Among the aliphatic
aldehydes, cylohexanecarboxaldehyde and propanal yielded the
corresponding annulated adducts 3n and 3o in 99 and 87%
yield, respectively. Unfortunately, when the annulation process
was attempted with trifluoroacetaldehyde ethyl hemiacetal, the
2-trifluoromethyl piperazine was not obtained. Similarly, the
reactions with ketones failed during the prerequisite ketimine
formation. Despite several dehydration conditions tested, the
predominant product was the 4-benzylpiperazin-2-one, result-
ing from the intramolecular lactamization of substrate 1, with
no traces of the desired ketimine.
Scheme 2. Proposed Mechanism for Ir-based Catalyst
Following the development of the above carboxylic amine
protocol, we discovered that the transformation proceeds very
quickly under batch conditions, with the reaction being over in
∼30 min. This observation prompted us to transpose this
reaction from batch to continuous mode. Compared with
classical batch processes, an increased surface exposed to light
and more homogeneous irradiation are among the multiple
benefits of continuous-flow conditions for light-mediated
reactions.19 As a powerful tool in organic synthesis, flow
chemistry has now become common in a wide range of
chemical industries, including the pharmaceutical sector for
drug discovery, development, and manufacturing.20 In the
photocatalysis area, a good number of batch transformations
have been transposed to continuous-flow processes.21
The batch conditions for the carboxylic amine protocol were
not directly transposable to flow conditions due to the
presence of solids that could clog the flow device. A precipitate,
most probably potassium trifluoroacetate, forms during the
course of the reaction when KOH is used. This led us to
replace KOH by 1,8-diazabicyclo[5.4.0]undec-7-ene, which
does not form a precipitate during the reaction. In addition, we
decided to test the flow transformation in the presence of the
4CzIPN. This photocatalyst, despite its requirement for higher
loading than Ir1, is particularly cost-attractive and, being
purely organic, does not contain the expensive and potentially
toxic iridium heavy metal, residual traces of which would have
to be tightly controlled in the piperazine if the end use
included biological testing. (The permitted daily exposure for
Ir is 100 ppm/day for oral route administration and 10 ppm/
day for I.V.)
Similarly to the batch procedure, the imine was preformed
for 30 min before being mixed into a methanol/acetonitrile (4/
1) solution containing the photoinitiator (Table 2). After
degassing, the mobile phase was introduced into a Vaportec
photoreactor at an initial flow rate of 1.5 mL·min−1 within 6.7
min of residence time. This led to the piperazine 3a in 65%
isolated yield (entry 1). Gratifyingly, an improved yield of 80%
was obtained when the residence time was reduced to only 3
min (entry 3). Finally, a scale-up continuous experiment from
0.2 to 2.5 mmol led to the photoannulated adduct in 77%
isolated yield within ∼30 min (entry 5).
amino moiety is suspected to be oxidized by the photoexcited
iridium catalyst [Ir(ppy)2(dtbpy)]PF6.16 A consecutive de-
carboxylation would lead to the α-amino radical, which then
would undergo an intramolecular addition onto the imine.
From the resulting N-centered radical, two pathways can be
hypothesized. In accordance with the literature, following path
A, this latter radical might be reduced by the Ir(II) species to
give, after protonation by methanol or water, the piperazine.
Although this reduction might first seem to be unfavorable
red
(E1/2 = −1.70 V vs SCE for dialkylaminyl radicals and
E1/2red[Ir(III)/Ir(II)] = −1.51 V vs SCE), Bode has proposed a
stabilizing effect of the adjacent substituents, thus rendering
the reduction feasible.10 Because we found that the reaction
could be performed in the presence of 4CzIPN, which has an
even less favorable reduction potential (E1/2red(4CzIPN/
4CzIPN−) = −1.21 V vs SCE), we assume that another
mechanism could occur through path B. As such, we envision
that the N-centered radical could abstract a hydrogen atom
from acetonitrile (bond dissociation energy D298(H−CH2CN)
= 405.8
4.2 kJ mol−1)17 to afford the piperazine and the
cyanomethyl radical •CH2CN. The latter can be readily
reduced by the photocatalyst (E1/2red[•CH2CN/−CH2CN] =
−0.72 V),18 thereby closing the catalytic cycle.
With suitable conditions established, that is, 1 equiv of
amino acid, 1.4 equiv of aldehyde, 4.1 equiv of KOH, and 1
mol % of Ir1, the scope of the annulation process was
examined with a variety of aldehydes (Scheme 3). These
include diversely substituted benzaldehyde derivatives, hetero-
aromatics, as well as aliphatic aldehydes. For the benzalde-
hydes, this study revealed that a wide range of substituents,
including electron-donating or -withdrawing ones attached to
the benzaldehyde in the ortho, meta or para position, are well-
tolerated, furnishing the corresponding piperazines in up to
In summary, we have demonstrated that a straightforward
synthesis of 2-aryl, 2-heteroaryl, as well as 2-alkyl piperazines is
possible through a photoinitiated decarboxylative annulation
protocol between a diamine and a large variety of aldehydes.
Advantages include easy access to the building block 1 derived
from the natural amino acid glycine, the use of a purely organic
C
Org. Lett. XXXX, XXX, XXX−XXX